Official Publications Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/07/2025 BST			5-day change	1st Jan Change
112.09 ^USD	+2.23%		+0.28%	+21.35%

07-14	Gilead Says Yeztugo Shows Broad Effectiveness, Tolerability for Diverse HIV Prevention	MT
07-14	Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for Hiv Prevention At Ias 2025	CI

Shareholders meeting voting results	05-06	CO
SEC Filing 10Q-1	05-06	CO
SEC Filing 8K	04-23	CO
Slide show Q1	04-23	CO
1st quarter results	04-23	CO
Proxy Statments	03-26	CO
SEC Filing 10K	02-27	CO
SEC Filing 8K	02-10	CO
Slide show results	02-10	CO
Annual results	02-10	CO
SEC Filing 13G	01-09	CO
SEC Filing 13G	12-18	CO
SEC Filing 8K	11-19	CO
SEC Filing 10Q-3	11-11	CO
SEC Filing 4K	11-06	CO
SEC Filing 4K	11-05	CO
Slide show Q3	11-05	CO
3rd quarter results	11-05	CO
SEC Filing 8K	11-05	CO
SEC Filing 4K	27/10/24	CO
SEC Filing 4K	01/10/24	CO
SEC Filing 4K	12/09/24	CO
SEC Filing 4K	11/09/24	CO
SEC Filing 4K	10/09/24	CO
SEC Filing 4K	09/09/24	CO

Time To Grow PFL Fanbase, Revenue: CEO John Martin

July 11, 2025 at 09:09 am